BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17637691)

  • 1. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant.
    Soule BP; Simone NL; Savani BN; Ning H; Albert PS; Barrett AJ; Singh AK
    Bone Marrow Transplant; 2007 Sep; 40(6):573-8. PubMed ID: 17637691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant.
    Singh AK; Karimpour SE; Savani BN; Guion P; Hope AJ; Mansueti JR; Ning H; Altemus RM; Wu CO; Barrett AJ
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):520-7. PubMed ID: 16965994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.
    Savani BN; Montero A; Wu C; Nlonda N; Read E; Dunbar C; Childs R; Solomon S; Barrett AJ
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):223-30. PubMed ID: 15744241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
    Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
    Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.
    Della Volpe A; Ferreri AJ; Annaloro C; Mangili P; Rosso A; Calandrino R; Villa E; Lambertenghi-Deliliers G; Fiorino C
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):483-8. PubMed ID: 11872296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
    Gopal R; Ha CS; Tucker SL; Khouri IF; Giralt SA; Gajewski JL; Andersson BS; Cox JD; Champlin RE
    Cancer; 2001 Oct; 92(7):1949-58. PubMed ID: 11745270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation.
    Singh AK; Savani BN; Albert PS; Barrett AJ
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):339-44. PubMed ID: 17317587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients.
    Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae R; Kimmig BN
    Strahlenther Onkol; 2007 Oct; 183(10):545-51. PubMed ID: 17896085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
    Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts.
    Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae RM
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):194-202. PubMed ID: 17869024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
    Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies.
    Lohr F; Wenz F; Schraube P; Flentje M; Haas R; Zierhut D; Fehrentz D; Hunstein W; Wannenmacher M
    Radiother Oncol; 1998 Jul; 48(1):45-51. PubMed ID: 9756171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis.
    Oya N; Sasai K; Tachiiri S; Sakamoto T; Nagata Y; Okada T; Yano S; Ishikawa T; Uchiyama T; Hiraoka M
    Int J Hematol; 2006 Jan; 83(1):86-91. PubMed ID: 16443559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
    van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen YH; Cheung T; Vijayakumar S; Hoffman R; Sosman J
    Bone Marrow Transplant; 2003 Jul; 32(1):9-13. PubMed ID: 12815472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
    Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.
    Akahane K; Shirai K; Wakatsuki M; Suzuki M; Hatanaka S; Takahashi Y; Kawahara M; Ogawa K; Takahashi S; Oyama-Manabe N; Ashizawa M; Kimura SI; Kako S; Kanda Y
    J Radiat Res; 2021 Sep; 62(5):918-925. PubMed ID: 34350969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total body irradiation using a modified standing technique: a single institution 7 year experience.
    Harden SV; Routsis DS; Geater AR; Thomas SJ; Coles C; Taylor PJ; Marcus RE; Williams MV
    Br J Radiol; 2001 Nov; 74(887):1041-7. PubMed ID: 11709470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.